M42's Abu Dhabi Health Data Services and TELUS Health to collaborate on AI-powered healthcare innovation across the UAE and broader region

Rhea-AI Summary

Abu Dhabi Health Data Services (M42) and TELUS Health (NYSE:TU) announced a strategic collaboration to deliver AI‑powered, personalized employee wellbeing solutions across the UAE and the region. The partnership will adapt a 40+ module Employee Assistance Program into local languages and explore next‑generation AI and precision medicine capabilities.

The initiative aims to reduce absenteeism, improve productivity and scale integrated digital health services using ADHDS infrastructure such as Malaffi, Sahatna and virtual hospital platforms.

News Market Reaction

+0.56%

1 alert

+0.56% News Effect

On the day this news was published, TU gained 0.56%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

EAP modules: more than 40 modules

1 metrics

EAP modules more than 40 modules Employee Assistance Program content scope in UAE collaboration

Market Reality Check

Price: $13.93 Vol: Volume 4,347,786 vs 20-da...

normal vol

$13.93 Last Close

Volume Volume 4,347,786 vs 20-day average 5,411,550 indicates activity below recent norms. normal

Technical Shares at $14.23, trading below 200-day MA of $15.11 and 14.97% under the 52-week high.

Peers on Argus

TU is up 0.71% while key telecom peers like BCE, SATS, RCI, VIV, and CHTR all sh...

TU is up 0.71% while key telecom peers like BCE, SATS, RCI, VIV, and CHTR all show gains between 1.49% and 3.02%, but no peers appear in the momentum scanner and no same-day peer news is flagged.

Previous Partnership,AI Reports

2 past events · Latest: Jul 30 (Positive)

Same Type Pattern 2 events

Date	Event	Sentiment	Move	Catalyst
Jul 30	AI cloud partnership	Positive	-0.4%	Launched Canadian sovereign AI cloud with OpenText using TELUS data centers.
Mar 04	AI venture expansion	Positive	-0.7%	Expanded MCE partnership after successful generative AI pilot in device app.

Pattern Detected

Past AI partnership announcements with TELUS have coincided with modest negative next-day moves despite strategically positive themes.

Recent Company History

Over the past months, TELUS has combined balance sheet actions with digital and AI expansion. A July 30, 2025 sovereign AI partnership with OpenText and a March 4, 2025 generative AI venture with MCE both focused on AI-enabled platforms and customer engagement. Those partnership/AI releases saw next-day moves of -0.37% and -0.65%. Today’s M42/TELUS Health collaboration similarly extends TELUS’ AI footprint, this time into employee wellbeing and healthcare delivery in the UAE and surrounding region.

Historical Comparison

partnership,AI

-0.5 %

Average Historical Move

Historical Analysis

In the past year, TELUS reported two AI partnership announcements tagged similarly, with an average next-day move of -0.51%, suggesting historically muted-to-negative reactions to such collaborations.

Typical Pattern

TELUS has evolved AI partnerships from Canadian sovereign cloud and retail-device engagement toward broader health and wellbeing applications with international partners.

Market Pulse Summary

This announcement expands TELUS Health’s AI footprint through a partnership with M42’s ADHDS to deli...

Analysis

This announcement expands TELUS Health’s AI footprint through a partnership with M42’s ADHDS to deliver a localized Employee Assistance Program with more than 40 wellbeing modules across the UAE. It builds on earlier AI partnerships that historically produced modest share reactions near -0.51%. Investors may track how the program scales across Malaffi and other digital platforms, the pace of employer adoption, and evidence of measurable productivity and engagement outcomes as indicators of strategic impact.

Key Terms

precision medicine, employee assistance program, ai-powered, health information exchange, +1 more

5 terms

precision medicine medical

"combine wellness, precision medicine and AI-driven healthcare innovation"

Precision medicine uses a person’s unique genetic makeup, lifestyle and environment to choose treatments and preventive steps that are more likely to work for them than one-size-fits-all approaches. For investors, it matters because it can make therapies more effective and efficient—think tailoring a suit rather than buying off the rack—affecting drug development costs, market size, pricing power and the speed at which therapies win regulatory approval.

employee assistance program technical

"ADHDS will work with TELUS Health on an Employee Assistance Program (EAP)"

A program offered by employers that gives workers confidential access to short-term counseling, mental-health support, and practical help like legal or financial referrals; think of it as a workplace safety net or hotline for personal and work-related problems. Investors care because effective programs can reduce absenteeism, lower healthcare and turnover costs, and protect a company’s productivity and reputation, which in turn can affect long-term financial performance.

ai-powered technical

"a truly transformative AI-powered employee assistance program tailored to the needs"

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

health information exchange medical

"including Malaffi, the region's first Health Information Exchange alongside Sahatna"

A health information exchange is a secure electronic system that lets hospitals, clinics and other care providers share patient medical records, test results and treatment histories so the right information is available when and where it’s needed. For investors, HIEs matter because they can reduce healthcare costs, improve patient outcomes and create demand for software, services and data-security solutions—similar to how a shared road network enables businesses to operate more efficiently and scale.

e-prescription medical

"alongside Sahatna, e-prescription, Shafafiya, and virtual hospital platforms"

An e-prescription is a doctor’s medicine order sent electronically from a clinician’s computer to a pharmacy instead of on paper. Like emailing a grocery list directly to a store, it speeds up filling prescriptions, reduces errors, and creates digital records that affect billing, patient data flows, and compliance. Investors watch adoption rates and regulatory changes because they influence pharmacy volumes, software and services revenue, cost savings, and legal risk for healthcare providers.

AI-generated analysis. Not financial advice.

Strategic alignment announced at the Dubai World Health Expo 2026 combines global healthcare expertise with digital health innovation to explore new comprehensive, workforce wellbeing solutions

ABU DHABI, United Arab Emirates and VANCOUVER, BC, Feb. 10, 2026 /PRNewswire/ - Abu Dhabi Health Data Services (ADHDS), part of the M42 group, and TELUS Health, announced a strategic agreement to introduce new personalized employee wellbeing solutions in the UAE that combine wellness, precision medicine and AI-driven healthcare innovation. As part of M42's mission to shift health from reactive care to predictive, personalized wellbeing at scale, ADHDS will work with TELUS Health on an Employee Assistance Program (EAP) that currently includes more than 40 modules addressing emotional, lifestyle and wellbeing support. Delivered in local languages for enhanced user experience, the EAP will help improve workplace focus, lowering absenteeism rates while also enabling employers to achieve measurable improvements in productivity and engagement.

"By combining TELUS Health's global expertise with M42's ADHDS digital health capabilities, we are delivering a truly transformative AI-powered employee assistance program tailored to the needs of employees in the UAE," said Kareem Shahin, Chief Executive Officer, Digital Health Solutions Platform, and Group Chief Digital Officer, M42. "This solution is designed to support the creation of a health and wellbeing environment where people can thrive, enabling healthier and more resilient communities."

Both ADHDS and TELUS Health will also explore the development of next-generation AI solutions to increase efficiencies and access to care, and progress precision medicine capabilities for tailored health treatments and early preventive interventions for employees

"The UAE and the region are experiencing a fundamental shift in how organizations approach employee wellbeing," said Mohamed El-Demerdash, President, TELUS Health. "Our agreement with M42's ADHDS positions us to be part of that transformation, exploring how our market-leading solutions and world-class mental health support could help employers and their employees. With M42's ADHDS digital expertise, we have the potential to deliver wellness at scale while respecting the unique cultural context of the region."

ADHDS delivers a robust portfolio of solutions including Malaffi, the region's first Health Information Exchange alongside Sahatna, e-prescription, Shafafiya, and virtual hospital platforms deployed internationally. Utilizing this digital infrastructure, ADHDS' wellbeing offering will benefit from scalable, integrated and secured health technology to deliver measurable outcomes for employers and employees across the UAE and the region

Together, the organizations have a prime opportunity to combine digital infrastructure, AI innovation, and clinical expertise to strengthen healthcare across the UAE and the region, building more resilient health systems and healthier communities.

About M42
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.

Established in 2023, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.

Abu Dhabi Health Data Services LLC (ADHDS)
M42's Abu Dhabi Health Data Services (ADHDS) is a premier digital healthcare solutions company serving as a strategic catalyst for advancing the healthcare ecosystem in Abu Dhabi and beyond. ADHDS digitally empowers health by championing innovative solutions to elevate the quality of care, expand access, optimise costs, and unlock efficiencies on a national, regional, and global scale. Harnessing the power of data and technology, ADHDS drives transformative change across the healthcare eco-system and makes a lasting impact on the communities they serve.

ADHDS was established in 2018 as a Private-Public Partnership (PPP) with the Department of Health Abu Dhabi (DOH) to build and operate Malaffi, the trailblazing Abu Dhabi Health Information Exchange (HIE). Following the successful delivery of Malaffi, as one of the fastest rolled-out and most advanced HIEs globally, ADHDS has become renowned for successfully delivering major national digital healthcare transformational projects, acting as a critical link between regulators, governments, healthcare providers, biopharma companies, and patient communities. ADHDS is an asset of M42, a global health leader powered by artificial intelligence and technology to transform care for all.

About TELUS Health
TELUS Health empowers people to live healthier lives and helps organizations create more productive, wellbeing-focused workplaces through global leadership in healthcare technology. Operating in more than 200 countries and territories, we support more than 160 million people at every point of their physical, mental, and financial wellbeing journey.

Our integrated approach connects the entire healthcare ecosystem: comprehensive workforce wellbeing programs, compassionate and personalized preventive care, and the technology infrastructure that healthcare practitioners and payors rely on daily. This creates seamless care pathways delivering regionalized and gender-responsive support, where and when people need it most.

Through our data-driven insights and proprietary research we are reshaping healthcare with earlier intervention and culturally-attuned approaches so individuals and organizations can thrive. Follow us as we advance our mission to become the world's most trusted wellbeing company: telushealth.com

For media inquiries and interview opportunities, please contact:

TELUS Health
Jill Yetman
jill.yetman@telus.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/m42s-abu-dhabi-health-data-services-and-telus-health-to-collaborate-on-ai-powered-healthcare-innovation-across-the-uae-and-broader-region-302683495.html

SOURCE TELUS Health

FAQ

What did ADHDS and TELUS Health announce on February 10, 2026 regarding employee wellbeing (TU)?

They announced a strategic collaboration to deploy an AI‑powered Employee Assistance Program across the UAE. According to ADHDS and TELUS Health, the program includes more than 40 modules covering emotional, lifestyle and wellbeing support delivered in local languages for workplace impact.

How will the ADHDS and TELUS Health partnership affect absenteeism and productivity for UAE employers (TU)?

The partnership intends to lower absenteeism and improve productivity through a tailored wellbeing program. According to the companies, localized modules and integrated digital services aim to deliver measurable improvements in workplace focus, engagement and employee resilience over time.

What role will AI and precision medicine play in the ADHDS and TELUS Health collaboration (TU)?

AI and precision medicine will be explored to enable predictive, personalized wellbeing and earlier interventions. According to the companies, they plan to develop next‑generation AI solutions to increase care access, efficiency and tailored treatments for employees across the region.

Which ADHDS digital platforms will support the TELUS Health EAP deployment in the UAE (TU)?

The EAP will leverage ADHDS digital infrastructure including Malaffi, Sahatna, e‑prescription and virtual hospital platforms. According to ADHDS, this integrated, secured technology stack will help scale wellbeing services and deliver measurable employer and employee outcomes.

What geographic scope and cultural considerations will the ADHDS–TELUS Health program target (TU)?

The program targets the UAE and the broader region with culturally adapted wellbeing solutions. According to the partners, local language delivery and regional digital expertise aim to respect cultural context while enabling wellness at scale for employers and employees.